Original Research
Corporate social responsibility: A pharmaceutical analysis
D. J. Theron
About the author(s)
D. J. Theron, University of Johannesburg, South Africa
Abstract
In the modern business environment organisations need to address two important aspects affecting their operations: the quality of management and the impact of their operations on the well-being of the society in which they operate. This dualism often results in economic, political and social dilemmas influencing the viability of organisations in general, and more specifically and recently, local and international pharmaceutical organisations operating in South Africa. This article considers the aspect of corporate social responsibility (CSR) in general and attempts to identify the social-related issues impacting on the pharmaceutical industry by means of content analysis - a research technique for making replicable and valid inferences from data. It furthermore describes the re-action of pharmaceutical organisations when confronted with such social demands, and finally analyses the management of CSR against four criteria of CSR. The article confirms the importance of managers to manage CSR towards society in a proactive manner. It furthermore suggests that the "hard" factors of strategic management and financial performance should be balanced with "soft" social/people issues. It also recommends that the industry should consider - and if applicable - endorse the concept of Issues Management as an approach to the proactive management of CSR.
Keywords
No related keywords in the metadata.
Metrics
Total abstract views: 5055
Total article views: 5943
Crossref Citations
1. A Demographic Analysis of Social Sustainability Performance in South Africa
Sandra Perks, Elroy E. Smith
International Journal of Social Science and Humanity vol: 5 issue: 6 first page: 553 year: 2015
doi: 10.7763/IJSSH.2015.V5.516
2. The relationship among corporate social responsibility, sustainability and organizational performance in pharmaceutical sector: a literature review
Kanika Saxena, Sunita Balani, Pallavi Srivastava
International Journal of Pharmaceutical and Healthcare Marketing vol: 15 issue: 4 first page: 572 year: 2021
doi: 10.1108/IJPHM-12-2020-0104